ENDRA Life Sciences Inc. (NDRA) NASDAQ
5.04
-0.56(-10.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
5.04
-0.56(-10.00%)
Currency In USD
| Market Cap | 3.57M |
| Enterprise Value | 3.3M |
| P/E Ratio | -0.83 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 3.38 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.62 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -2.12 |
| Return On Equity | -5.13 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -5.61M |
| Net Income | -7.03M |
| Diluted EPS | -8.93 |
| Total Cash | 356,462 |
| Total Cash/Share | 0.3 |
| Total Debt | 461,206 |
| Total Debt/Equity | 0.26 |
| Current Ratio | 0.64 |
| Book Value Per Share | 1.49 |
| 52-Week Change | 40.78 |
| 52-Week High | 11.96 |
| 52-Week Low | 2.96 |
| Moving Average 50 Days | 5.02 |
| Moving Average 200 Days | 4.88 |
| Average Volume | 35,073 |
| Shares Outstanding | 752,631 |
| % Held by Institutions | 0.01 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:35 |
| Last Split Date | November 07, 2024 |